Published: 09-07-2019

Foreword

The nutraceuticals: a new therapeutic strategy in the management of digestive and respiratory disorders

Giorgio Ciprandi, Salvo Emanuele Aragona, Lorenzo Drago, Ignazio La Mantia
Abstract 261 | PDF Downloads 69 | DOI https://doi.org/10.23750/abm.v90i7-S.8648

Page 5-7

Original articles

Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders

Luigi Bonavina, Andrea Arini, Leonardo Ficano, Donato Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Giorgio Ciprandi, Italian Study Group on digestive disorders
Abstract 450 | PDF Downloads 140 | DOI https://doi.org/10.23750/abm.v90i7-S.8649

Page 8-12

Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation

Luigi Bonavina, Andrea Ariani, Leonardo Ficano, Domenico Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Lorenzo Drago, Giorgio Ciprandi, Italian Study Group on digestive disorders
Abstract 364 | PDF Downloads 111 | DOI https://doi.org/10.23750/abm.v90i7-S.8650

Page 13-17

Post-surgical intestinal dysbiosis: use of an innovative mixture (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01)

Luigi Bonavina, Andrea Arini, Leonardo Ficano, Donato Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Giorgio Ciprandi, Italian Study Group on digestive disorders
Abstract 430 | PDF Downloads 145 | DOI https://doi.org/10.23750/abm.v90i7-S.8651

Page 18-23

Broncalt®, class II medical device, in patients with acute upper airways disease: a survey in clinical practice

Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
Abstract 312 | PDF Downloads 59 | DOI https://doi.org/10.23750/abm.v90i7-S.8654

Page 24-29

Broncalt®, class II medical device, in patients with chronic upper airways disease: a survey in clinical practice

Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
Abstract 420 | PDF Downloads 72 | DOI https://doi.org/10.23750/abm.v90i7-S.8655

Page 30-35

Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice

Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
Abstract 447 | PDF Downloads 55 | DOI https://doi.org/10.23750/abm.v90i7-S.8656

Page 36-40

VAS for assessing the perception of antihistamines use in allergic rhinitis

Giorgio Ciprandi, Ignazio La Mantia
Abstract 213 | PDF Downloads 53 | DOI https://doi.org/10.23750/abm.v90i7-S.8657

Page 41-44

Influence of cigarette smoking on allergic rhinitis: a comparative study on smokers and non-smokers

Calogero Grillo, Ignazio La Mantia, Caterina M Grillo, Giorgio Ciprandi, Martina Ragusa, Claudio Andaloro
Abstract 381 | PDF Downloads 242 | DOI https://doi.org/10.23750/abm.v90i7-S.8658

Page 45-51

Oral health in children with sleep-disordered breathing: a cross-sectional study

Calogero Grillo, Ignazio La Mantia, Graziano Zappala, Salvatore Cocuzza, Giorgio Ciprandi, Claudio Andaloro
Abstract 453 | PDF Downloads 177 | DOI https://doi.org/10.23750/abm.v90i7-S.8661

Page 52-59